National patterns of care and cancer-specific outcomes of adjuvant treatment in patients with serous and clear cell endometrial carcinoma.
CONCLUSIONS: Our results suggest brachytherapy benefits stages I-II serous/clear cell cancers, chemotherapy benefits stage III serous/clear cell cancers, and both chemotherapy and brachytherapy benefit stages I-II serous cancers.
PMID: 30551884 [PubMed - as supplied by publisher]
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Xiang M, English DP, Kidd EA Tags: Gynecol Oncol Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Cancer of the Uterus | Carcinoma | Chemotherapy | Endometrial Cancer | External Beam Therapy | Hysterectomy | Medicare | Serous Carcinoma | Study